08:00 , Feb 9, 2015 |  BC Week In Review  |  Clinical News

Cobas TaqScreen MPX Test v2 regulatory update

FDA approved Roche’s cobas TaqScreen MPX Test v2.0 to detect and identify HIV, HCV and HBV in donated human blood and blood components. The real-time PCR in vitro test, which has CE Mark approval and...
07:00 , May 30, 2011 |  BC Week In Review  |  Clinical News

Cobas TaqScreen MPX Test v2 regulatory update

Roche received CE Mark approval for its cobas TaqScreen MPX v2.0 to detect HIV, HCV and HBV in donated human blood and blood components. The real-time PCR in vitro test, which is already available in...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Clinical News

Cobas TaqScreen MPX Test regulatory update

FDA approved an sBLA from Roche to expand the use of its cobas TaqScreen MPX test to detect HIV, HBV and HCV in source plasma. The real-time PCR single-assay detection test was approved in the...
08:00 , Jan 5, 2009 |  BC Week In Review  |  Clinical News

Cobas TaqScreen MPX Test regulatory update

FDA approved a BLA from Roche for its cobas TaqScreen MPX Test to screen for HIV-1, HIV-2, HCV and HBV in donated blood. The real-time PCR single-assay detection test is approved in Europe. Roche (SWX:ROG),...
07:00 , Mar 12, 2007 |  BC Week In Review  |  Clinical News

Cobas TaqScreen MPX Test regulatory update

FDA accepted for filing a BLA from ROG's Roche Diagnostics subsidiary for the Cobas TaqScreen MPX Test to detect HIV-1, HIV-2, HCV and HBV in blood. The PCR-based assay is approved in Europe. Roche (SWX:ROG),...